MedElevator
Войти в исследования Development of a High-Risk Medication List for Australian Residential Aged Care: A Modified Delphi Study.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cross Amanda J, Chaudhry Madiha, Goordeen Darshna, Breen Juanita L, Clark Malcolm, Daly Stephanie, Delardes Belinda, Hart Bente, Hawthorne Deborah, Hayball Peter J, Hilmer Sarah N, Kouladjian O'Donnell Lisa, Kulh MaryAnn, Lee Kenneth, Liew David F L, Macfarlane Stephen, Manias Elizabeth, Marinucci Anthony, Pond Constance Dimity, Rawson Helen, Slatyer Susan, Stafford Andrew, Thomson Amy B, Wang Kate, Wasef Kirolos, Zimmerman Jonathan, Andrew Nadine E, Godbole Gauri P, Lord Louise, Manek Atish, McInerney Brigid, Steeper Michelle, Turner Justin P, Bell J Simon
Аннотация
METHODS: A 3-round modified Delphi study involving Australian healthcare professionals was conducted. In Round 1, participants indicated their level of agreement, on a 9-point Likert scale, whether 60 medications/medication classes were considered high-risk and should be included in a high-risk medication list for Australian residential aged care. Round 2 included medications/medication classes that did not reach consensus and new medications identified by participants. Consensus was defined as 70% or more of participants responding at 7 or higher on the Likert scale. In Round 3, participants were asked to prioritise medications/medication classes that reached consensus in Round 1 or 2.
RESULTS: In total, 42 participants completed Round 1, and 35 (83%) completed all three rounds. Participants included pharmacists (n = 21), prescribers (n = 15), nurses (n = 5) and a paramedic (n = 1), with representation from all Australian states and mainland territories. Overall, 26 medications reached consensus (21 in Round 1, five in Round 2) and were categorised into 15 medications/medication classes for prioritisation in Round 3. The final prioritisation list was opioids, insulin, benzodiazepines, anticoagulants, z-drugs, antipsychotics, lithium, sulfonylureas with high risk of hypoglycaemia, chemotherapeutic agents, methotrexate, digoxin, narrow therapeutic range antiepileptics, tricyclic antidepressants, immunosuppressants for transplant and sedating antihistamines.
DISCUSSION: This is the first, national consensus list of high-risk medications developed specifically for Australian residential aged care. It can be used to implement targeted strategies to minimise medication-related harm.